1.72 -0.03 (-1.71%)
AEZS
| Trade AEZS now with |
|
Stock Details
Last Trade:1.72 Change:-0.03 (-1.71%) Prev Close:1.75 Open: 1.75 Days Range:1.71 – 1.77 52 Week Range: 1.35 - 2.68 Volume:530100 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/12
Recent Alert on 02/03/12 at 7:40am
Aeterna Zentaris (AEZS) Updates on AEZS-108 Phase 1/2; Low Does Still Show Some Antitumor Acticity
Aeterna Zentaris (AEZS) Updates on AEZS-108 Phase 1/2; Low Does Still Show Some Antitumor Acticity
Aeterna Zentaris Inc. (Nasdaq: AEZS) reported positive updated results for the Phase 1 portion of its ongoing Phase 1/2 study in castration- and taxane-resistant prostate cancer (CRPC) with AEZS-108 (zoptarelin doxorubicin), the Company's targeted... Read More
Recent Alert on 02/03/12 at 7:40am
Aeterna Zentaris (AEZS) Updates on AEZS-108 Phase 1/2; Low Does Still Show Some Antitumor Acticity
Aeterna Zentaris (AEZS) Updates on AEZS-108 Phase 1/2; Low Does Still Show Some Antitumor Acticity
Recent Alert on 01/24/12 at 10:08am
Aeterna Zentaris (AEZS) Announces New At-the-Market Sales Agreement of Up 10.4 Million Shares
Aeterna Zentaris (AEZS) Announces New At-the-Market Sales Agreement of Up 10.4 Million Shares
View AllRecent Press Releases
Press Release on 02/07/12 at 7:30am
Aeterna Zentaris to Present at BIO CEO Investor and RBC Capital Markets Global Healthcare Conferences in New York
Aeterna Zentaris to Present at BIO CEO Investor and RBC Capital Markets Global Healthcare Conferences in New York
View AllRecent SEC Filings
No Recent SEC Filings Available